Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 105.8 SEK -0.19% Market Closed
Market Cap: 10.7B SEK
Have any thoughts about
Biogaia AB?
Write Note

P/FCFE
Price to FCFE

30.1
Current
34.8
Median
27.3
Industry
Lower than median
Higher than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
30.1
=
Market Cap
10.7B SEK
/
FCFE
355.1m SEK
All Countries
Close
Market Cap P/FCFE
SE
Biogaia AB
STO:BIOG B
10.7B SEK 30.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 183 345.6
US
Abbvie Inc
NYSE:ABBV
301B USD 12.1
US
Amgen Inc
NASDAQ:AMGN
162B USD 27.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD -91.1
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -431
AU
CSL Ltd
ASX:CSL
138B AUD 81.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 26.7
US
Seagen Inc
F:SGT
39.3B EUR -59.3
NL
argenx SE
XBRU:ARGX
34.1B EUR -108.8

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A

See Also

Discover More